NCT01743079View on ClinicalTrials.gov

Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B

PHASE4CompletedINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Chronic Hepatitis BLate PregnancyTransmissionComplication

Interventions

DRUG

Telbivudine

LdT 600mg QD

DRUG

Lamivudine

LAM 100mg QD

Trial Locations (1)

100069

Beijing YouAn Hospital, Beijing

Sponsors

Collaborators (1)

New Discovery LLC

All Listed Sponsors

collaborator

New Discovery LLC

INDUSTRY

lead

Beijing YouAn Hospital

OTHER